Reconstitution
Reconstitution is not inherently required for methylcobalamin. Many injectable products are supplied as finished solutions.
BacScience Scientific Research Reference
Methylcobalamin (Vitamin B12) Reconstitution & Research Reference
Methylcobalamin, also called mecobalamin or MeB12, is a biologically active form of vitamin B12 involved in vitamin B12-dependent metabolism, particularly methionine synthase activity. This reference examines methylcobalamin formulations, reconstitution and diluent considerations, concentration calculations, stability, quality, sterility, clinical research and regulatory considerations.
Compound Methylcobalamin / Mecobalamin
Class Cobalamin / Vitamin B12 vitamer
CAS 13422-55-4
Formula C₆₃H₉₁CoN₁₃O₁₄P
Molecular mass ≈1,344.4 g/mol
Research areas B12 deficiency, neuropathy, nerve biology
Common forms Oral, sublingual, injectable
Evidence level Established nutrient; indication-specific clinical evidence
Regulatory status Formulation and jurisdiction dependent
Last reviewed September 2026
Methylcobalamin Reconstitution: Quick Answer
Does methylcobalamin commonly require reconstitution? No. Methylcobalamin is commonly encountered in finished oral or injectable formulations. A marketed methylcobalamin injection listed in DailyMed, for example, is a 1 mg/mL intramuscular solution rather than a dry powder requiring user reconstitution.
Is bacteriostatic water an established universal diluent? No. BacScience found no authoritative basis for treating BAC water as a universal diluent for methylcobalamin.
Are reconstitution instructions formulation-specific? Yes. If a particular methylcobalamin product is supplied as a powder or concentrate, its manufacturer, validated formulation documentation, pharmacy formulation record or applicable product labeling should establish the appropriate preparation method.
What determines concentration? The mathematical concentration depends on the amount of methylcobalamin and the final solution volume. It does not determine chemical compatibility, sterility, stability or clinical suitability.
Methylcobalamin Research Snapshot
Six core considerations help distinguish a mathematical concentration question from a genuine pharmaceutical formulation question.
Diluent
BAC water should not be assumed to be a validated methylcobalamin diluent. The exact formulation documentation controls.
Concentration
Concentration is a mass-to-volume calculation. A calculated value is not automatically a validated injectable concentration.
Quality
Identity, assay, impurities, material grade, container closure and traceability should be evaluated independently.
Clinical Evidence
Human research includes oral and intramuscular methylcobalamin as well as experimental high-dose intravenous research.
Regulatory Status
Regulatory status varies by country, product, dosage form and route. A listing should never be interpreted as universal approval.
What Is Methylcobalamin?
Methylcobalamin is one of the naturally occurring forms of vitamin B12. It is also called mecobalamin, MeCbl or methyl-B12.
Unlike cyanocobalamin, methylcobalamin contains a methyl group coordinated to the central cobalt atom. It is one of the two coenzyme forms of vitamin B12 used by human B12-dependent enzymes. :contentReference[oaicite:3]{index=3}
PubChem identifies methylcobalamin with CAS number 13422-55-4 and the molecular formula C₆₃H₉₁CoN₁₃O₁₄P, with a molecular weight of approximately 1,344.4 g/mol. :contentReference[oaicite:4]{index=4}
How Does Methylcobalamin Function Biologically?
Methylcobalamin functions as a coenzyme for methionine synthase, an enzyme involved in the conversion of homocysteine to methionine. Through this pathway, vitamin B12 participates in one-carbon metabolism and the regeneration of methionine from homocysteine.
Vitamin B12 is also essential for normal neurological function and hematopoiesis. Deficiency can affect blood-cell formation and the nervous system.
The biological importance of vitamin B12 does not mean that additional methylcobalamin necessarily produces benefits beyond correcting deficiency.
Methylcobalamin vs Other Vitamin B12 Forms
| Form | Key characteristic | Research / use context |
|---|---|---|
| Methylcobalamin | Methyl-coordinated cobalamin | Oral supplements and injectable products; neurological research |
| Cyanocobalamin | Cobalamin containing a cyano ligand | Widely used vitamin B12 form in supplements and pharmaceutical products |
| Hydroxocobalamin | Hydroxo ligand at cobalt | Injectable vitamin B12 formulation in several jurisdictions |
| Adenosylcobalamin | Adenosyl-coenzyme form | Important B12 coenzyme involved in methylmalonyl-CoA mutase |
NIH notes that dietary supplements may contain cyanocobalamin, methylcobalamin, adenosylcobalamin or hydroxocobalamin and that research has not established one supplemental form as universally superior to the others. :contentReference[oaicite:5]{index=5}
What Is Methylcobalamin Being Studied For?
Vitamin B12 Deficiency
Vitamin B12 supplementation is established for correcting vitamin B12 deficiency. The appropriate form and route depend on the underlying cause, severity and clinical circumstances.
Peripheral Neuropathy
Methylcobalamin has been investigated for peripheral neuropathy, diabetic neuropathy and other nerve-related conditions.
Nerve Repair Research
Experimental and clinical research has examined high-dose methylcobalamin in relation to axonal regeneration and peripheral nerve function.
Neurological Disease
High-dose methylcobalamin has also been studied experimentally in conditions such as amyotrophic lateral sclerosis and chronic peripheral neuropathy.
Human Clinical Research
Human research on methylcobalamin includes oral, intramuscular and intravenous administration. The evidence is highly route- and indication-specific.
| Route | Research context | Evidence interpretation |
|---|---|---|
| Oral | Vitamin B12 deficiency and diabetic neuropathy | Human randomized trials have evaluated oral methylcobalamin. |
| Intramuscular | Peripheral and diabetic neuropathy | Clinical trials have evaluated IM methylcobalamin against oral regimens and other treatments. |
| Intravenous | Experimental high-dose neurological research | Research exists, but these protocols should not be generalized to ordinary vitamin B12 replacement. |
Doses Studied in Clinical Research
The following values are examples of doses reported in clinical studies. They are presented as research data rather than dosing recommendations.
| Study | Route | Research regimen | Population |
|---|---|---|---|
| Peripheral neuropathy study | IM | 500 µg three times weekly vs 1,500 µg once weekly | Patients with peripheral neuropathy |
| Diabetic peripheral neuropathy RCT | IM | 0.5 mg/day, three times weekly for 8 weeks | Mild-to-moderate diabetic peripheral neuropathy |
| Peripheral neuropathy phase I/II research | IV | 25 mg/day for 10 days followed by monthly 25 mg | Chronic peripheral neuropathy |
| Diabetic neuropathy oral research | Oral | 1,000–2,000 µg/day | Type 2 diabetes with low B12 and neuropathy |
Research-dose warning:
Ultra-high-dose IV methylcobalamin studies are experimental protocols. They should not be interpreted as standard vitamin B12 replacement regimens or as instructions for preparing injectable research material.
A phase I/II study evaluated IV methylcobalamin at 25 mg/day for 10 days followed by monthly 25 mg doses in patients with chronic peripheral neuropathy. Fourteen patients were enrolled, with 12 completing the primary outcome evaluation. :contentReference[oaicite:6]{index=6}
Another clinical study compared IM methylcobalamin at 500 µg three times weekly with 1,500 µg once weekly in patients with peripheral neuropathy. :contentReference[oaicite:7]{index=7}
A randomized clinical trial comparing IM methylcobalamin with oral tablets in diabetic peripheral neuropathy evaluated 0.5 mg/day by injection three times weekly for eight weeks in the injection group. :contentReference[oaicite:8]{index=8}
A 2026 randomized clinical trial evaluated oral methylcobalamin at 1,000 or 2,000 µg/day for 16 weeks in adults with type 2 diabetes, diabetic peripheral neuropathy and low serum B12. Both groups showed improvements in neuropathic symptoms, with no significant difference between the two dose groups for the primary neuropathic outcomes. :contentReference[oaicite:9]{index=9}
Methylcobalamin Reconstitution Research
Methylcobalamin is not inherently a reconstitution-dependent compound.
Many commercial methylcobalamin preparations are already formulated as oral products or sterile injectable solutions.
For example, a DailyMed-listed methylcobalamin injection contains 1 mg/mL and is labeled for intramuscular administration. Importantly, that particular listing is classified as an unapproved drug and its labeling explicitly states that FDA has not found it safe and effective. :contentReference[oaicite:10]{index=10}
Therefore, a generic internet instruction such as "add X mL of BAC water to a methylcobalamin vial" is not scientifically justified unless the specific formulation documentation establishes that procedure.
When Reconstitution May Be Relevant
- A specific research material is supplied as a dry solid.
- The manufacturer provides validated reconstitution information.
- A qualified compounding process specifies the preparation method.
- The intended concentration and final volume are defined.
- Compatibility and stability have been established for the exact formulation.
When Reconstitution Should Not Be Assumed
- The product is already a finished injectable solution.
- No validated diluent is specified.
- The material is dietary-supplement grade.
- The product documentation does not establish sterile use.
- Stability after dilution has not been demonstrated.
Methylcobalamin Diluent Considerations
| Question | BacScience Position |
|---|---|
| Is BAC water a universal methylcobalamin diluent? | Not established |
| Does every methylcobalamin product require a diluent? | No |
| Are injectable products available as finished solutions? | Yes |
| Should the exact product documentation determine preparation? | Yes |
| Does mathematical solubility establish injectable suitability? | No |
Important:
Methylcobalamin's ability to dissolve in water does not establish that any particular bacteriostatic or sterile diluent is appropriate for a specific sterile formulation.
Methylcobalamin Concentration Calculator
Concentration is a mathematical relationship between the amount of methylcobalamin and the final solution volume.
Concentration (mg/mL) = Total methylcobalamin (mg) ÷ Final volume (mL)
Example for mathematical reference only: 1 mg of methylcobalamin in a final volume of 1 mL corresponds mathematically to 1 mg/mL.
Likewise, 1 mg in a final volume of 2 mL corresponds mathematically to 0.5 mg/mL.
These calculations do not establish that the concentration is chemically stable, sterile, clinically appropriate or suitable for injection.
Open Universal BAC Water Calculator
What the calculator does — and does not do
The BacScience calculator performs mathematical concentration and volume conversions.
It does not determine:
- chemical compatibility
- sterile formulation suitability
- endotoxin safety
- stability after dilution
- appropriate route of administration
- clinical dosing
Methylcobalamin Vial Quantity & Concentration
For a finished methylcobalamin solution, the labeled concentration and container volume determine the total quantity of active ingredient.
| Labeled concentration | Container volume | Mathematical total quantity |
|---|---|---|
| 1 mg/mL | 1 mL | 1 mg |
| 1 mg/mL | 2 mL | 2 mg |
| 0.5 mg/mL | 2 mL | 1 mg |
These are mathematical examples only. Actual product concentration and container volume must always be taken from the product label or certificate/documentation rather than inferred from an internet example.
Methylcobalamin Stability & Storage Research
Cobalamins are chemically complex molecules and their stability can be influenced by light, temperature, formulation composition, pH and container conditions.
Light Sensitivity
Vitamin B12 compounds are known to be sensitive to light. Product labeling should therefore be followed for light-protection and storage requirements.
Formulation-Specific Stability
Stability information from one methylcobalamin formulation should not automatically be transferred to another product, concentration, container or diluent.
Dry Material
Storage requirements for a dry analytical or research material can differ substantially from those of a finished injectable solution.
Reconstituted Material
If a specific formulation requires reconstitution, post-reconstitution stability should be supported by appropriate formulation or stability data.
Sterility & Endotoxin Considerations
Sterility is not a property that can be inferred from chemical identity or purity alone. A methylcobalamin material intended for sterile use requires appropriate manufacturing, handling and testing controls.
Research-grade material is not automatically injectable-grade material.
A certificate showing high methylcobalamin assay does not by itself establish sterility, endotoxin compliance, particulate control or suitability for injection.
Quality Attributes
- Identity
- Assay
- Related substances
- Residual solvents where applicable
- Water content where applicable
- Elemental impurities where relevant
Sterile-Use Attributes
- Sterility assurance
- Bacterial endotoxin control
- Particulate control
- Container-closure integrity
- Validated manufacturing process
- Appropriate storage and handling
Quality & Purity Considerations
Identity
Verify that the material is methylcobalamin rather than another cobalamin form.
Assay
Review the reported assay and analytical method rather than relying solely on a numerical purity percentage.
Material Grade
Distinguish analytical/research material from pharmaceutical-grade ingredients intended for sterile manufacturing.
Batch Traceability
Maintain lot numbers, supplier identity, analytical documentation and certificate-of-analysis records.
Endotoxin
Endotoxin requirements are particularly relevant to any material intended for parenteral research.
Stability
Stability data should correspond to the actual chemical form, formulation, concentration, container and storage condition.
Regulatory Status
Methylcobalamin has different regulatory positions depending on jurisdiction, formulation and route.
Japan's PMDA maintains official information for Mecobalamin injection products, including Mechicobal 500 µg injection manufactured by Eisai. This demonstrates that methylcobalamin is used in regulated injectable medicinal products in some jurisdictions. :contentReference[oaicite:11]{index=11}
In the United States, however, a DailyMed listing for a methylcobalamin injection explicitly identifies the product as an unapproved drug and states that FDA has not found it safe and effective. Therefore, a DailyMed listing should not be confused with FDA approval. :contentReference[oaicite:12]{index=12}
Regulatory principle:
Always distinguish the chemical compound itself from the regulatory status of a particular product.
Safety Findings
Vitamin B12 is generally considered to have a broad safety margin when used appropriately, but route, formulation, dose and patient characteristics remain important.
- Vitamin B12 deficiency should be appropriately diagnosed and its cause considered.
- Injection products can have formulation-specific excipients and contraindications.
- Rare hypersensitivity reactions can occur with injectable vitamin B12 products.
- Experimental high-dose IV methylcobalamin should not be equated with routine vitamin B12 replacement.
- The safety of a research-grade powder does not establish the safety of preparing it for parenteral administration.
Clinical Evidence Summary
| Research area | Evidence signal | Important limitation |
|---|---|---|
| B12 deficiency | Established | Appropriate form and route depend on clinical circumstances. |
| Peripheral neuropathy | Investigated | Studies differ substantially in design, route and population. |
| Diabetic neuropathy | Clinical evidence | Results should not be generalized to every neuropathy. |
| High-dose IV neuroregeneration | Experimental | Small or indication-specific studies; not standard B12 replacement. |
Research Limitations
- Methylcobalamin research uses multiple routes and formulations.
- Results from oral studies cannot automatically be transferred to injectable formulations.
- High-dose IV research represents a specialized experimental area.
- Different B12 vitamers should not be treated as identical products.
- Product concentration does not establish clinical efficacy.
- A mathematical dilution calculation does not establish sterile formulation suitability.
- Stability data must correspond to the actual formulation and storage conditions.
Frequently Asked Questions
What is methylcobalamin?
Methylcobalamin is a naturally occurring form of vitamin B12 and one of the two coenzyme forms of B12 used in human B12-dependent metabolism.
Is methylcobalamin the same as vitamin B12?
Methylcobalamin is a form, or vitamer, of vitamin B12. Vitamin B12 also exists as cyanocobalamin, hydroxocobalamin and adenosylcobalamin.
Does methylcobalamin need to be reconstituted?
Not necessarily. Many methylcobalamin products are supplied as finished oral or injectable formulations. Reconstitution is only relevant when the specific product is supplied in a form requiring preparation.
Can methylcobalamin be reconstituted with BAC water?
BAC water should not be assumed to be a universal methylcobalamin diluent. The appropriate diluent must be established from the exact product or validated formulation documentation.
How is methylcobalamin concentration calculated?
Concentration in mg/mL equals the amount of methylcobalamin in mg divided by the final solution volume in mL.
What is the molecular weight of methylcobalamin?
The molecular weight of methylcobalamin is approximately 1,344.4 g/mol.
What routes of methylcobalamin have been studied?
Human research includes oral, intramuscular and intravenous administration. Evidence differs substantially between routes.
Has high-dose intravenous methylcobalamin been studied?
Yes. Small clinical studies have investigated high-dose IV methylcobalamin for neurological conditions including peripheral neuropathy. These experimental protocols should not be interpreted as ordinary vitamin B12 replacement regimens.
Is methylcobalamin better than cyanocobalamin?
NIH notes that research has not established one supplemental B12 form as universally superior to the others.
Does the BacScience calculator determine the correct methylcobalamin diluent?
No. The calculator performs mathematical concentration and volume conversions. It does not establish chemical compatibility, sterility, endotoxin safety, stability or clinical suitability.
Can research-grade methylcobalamin be used for injection?
Research-grade material should not automatically be considered suitable for sterile injection. Injectable use requires appropriate pharmaceutical-quality controls, formulation, sterility and endotoxin controls.
Why should methylcobalamin and other B12 forms be distinguished?
Different cobalamin forms have different chemical structures and may have different formulation characteristics. Research findings should therefore be attributed to the actual B12 form studied.
Calculate Methylcobalamin Concentration
Use the BacScience Universal BAC Water Calculator for mathematical concentration and volume conversions. Always verify the actual formulation, diluent and storage requirements from authoritative product documentation.
Open BAC Water CalculatorScientific References
- NIH Office of Dietary Supplements. Vitamin B12 — Health Professional Fact Sheet.
- PubChem. Methyl Vitamin B12 / Methylcobalamin, CID 72784645.
- DailyMed. Methylcobalamin injection, NDC 70104-826-01. The listed product is identified as an unapproved drug.
- PMDA. Mecobal 500 µg injection / Mecobalamin injection information.
- Shibuya K, et al. Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy. Internal Medicine. 2014.
- Sil A, et al. Randomized study comparing methylcobalamin dosing regimens in peripheral neuropathy. Korean Journal of Pain. 2018.
- Zhang Y, et al. Mecobalamin intramuscular injections versus oral tablets in diabetic peripheral neuropathy. Scientific Reports. 2021.
- 2026 randomized clinical trial evaluating oral methylcobalamin 1,000 µg/day versus 2,000 µg/day in diabetic peripheral neuropathy with low serum vitamin B12.
Image Sources & Licensing
The molecular images used on this page are loaded directly from Wikimedia Commons and are not stored in the BacScience Shopify Files area.
- "Vitamin B12 - methylcobalamine 01.jpg" — PMoleman — CC BY-SA 4.0.
- "Vitamin B12 - different forms.jpg" — PMoleman — CC BY-SA 4.0.
If BacScience later wants full control over image availability, performance and licensing, the images can instead be downloaded and uploaded to Shopify Files.
Last Reviewed
September 11, 2026
Research and regulatory information should be periodically reviewed as new clinical studies, product labels and regulatory documents become available.
Research and educational information only. This page is intended as a scientific reference and does not provide individualized medical advice, prescribing instructions or instructions for preparing injectable medicines. Methylcobalamin products differ in chemical form, grade, formulation, concentration, route and quality controls. Mathematical concentration examples do not establish a suitable diluent, sterility, endotoxin compliance, stability or clinical dose. Injectable preparations should be handled according to applicable pharmaceutical, sterile-compounding and healthcare-professional requirements.